title: Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
authors.affiliation: McGuire Veterans Affairs Medical Center Richmond, Virginia 23249, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Hanrahan
authors.forename: H
authors.initials: H
authors.lastname: Ibrahim
authors.forename: D
authors.initials: D
authors.lastname: Tolman
authors.forename: D
authors.initials: D
authors.lastname: Kirchberg
authors.forename: D
authors.initials: D
authors.lastname: Salter
authors.forename: A
authors.initials: A
authors.lastname: Guerraty
authors.forename: P K
authors.initials: PK
authors.lastname: Mohanty
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008776:Methylprednisolone Hemisuccinate; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D008776:Methylprednisolone Hemisuccinate; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine